Risks and benefits of ovarian shielding in female patients undergoing TBI: a decision analysis

Bone Marrow Transplant. 2011 Aug;46(8):1145-7. doi: 10.1038/bmt.2010.240. Epub 2010 Oct 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Busulfan / adverse effects*
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Myeloablative Agonists / adverse effects*
  • Ovary / drug effects*
  • Ovary / transplantation*
  • Pregnancy
  • Whole-Body Irradiation / methods*

Substances

  • Myeloablative Agonists
  • Busulfan